Ame Company For Medical Supplies
TADAWUL:9527.SR
118 (SAR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 248.351 | 223.318 | 193.17 | 151.386 | 121.604 | 89.92 |
| Cost of Revenue
| 148.015 | 124.566 | 102.888 | 81.841 | 66.615 | 48.263 |
| Gross Profit
| 100.335 | 98.753 | 90.281 | 69.545 | 54.989 | 41.657 |
| Gross Profit Ratio
| 0.404 | 0.442 | 0.467 | 0.459 | 0.452 | 0.463 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 2.918 | 6.51 | 4.526 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 34.321 | 29.862 | 23.761 | 0 | 0 |
| SG&A
| 55.179 | 37.239 | 36.372 | 28.288 | 32.399 | 25.341 |
| Other Expenses
| 4.153 | 24.227 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 51.026 | 61.466 | 60.306 | 45.03 | 32.399 | 25.341 |
| Operating Income
| 49.309 | 37.286 | 29.975 | 24.514 | 22.59 | 16.317 |
| Operating Income Ratio
| 0.199 | 0.167 | 0.155 | 0.162 | 0.186 | 0.181 |
| Total Other Income Expenses Net
| 0.734 | 0.297 | 0.058 | -0.305 | -0.018 | -0.006 |
| Income Before Tax
| 50.044 | 37.583 | 30.033 | 24.21 | 22.571 | 16.311 |
| Income Before Tax Ratio
| 0.202 | 0.168 | 0.155 | 0.16 | 0.186 | 0.181 |
| Income Tax Expense
| 4.643 | 4.068 | 3.349 | 2.987 | 1.5 | 1.5 |
| Net Income
| 45.401 | 33.515 | 26.684 | 21.223 | 21.071 | 14.811 |
| Net Income Ratio
| 0.183 | 0.15 | 0.138 | 0.14 | 0.173 | 0.165 |
| EPS
| 6.49 | 4.79 | 3.81 | 3.05 | 3.01 | 2.12 |
| EPS Diluted
| 6.49 | 4.79 | 3.81 | 3.05 | 3.01 | 2.12 |
| EBITDA
| 52.04 | 39.325 | 30.99 | 24.837 | 22.881 | 16.425 |
| EBITDA Ratio
| 0.21 | 0.176 | 0.16 | 0.164 | 0.188 | 0.183 |